Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/13739
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, Rashmi-
dc.contributor.authorBasera, Sanjay Singh-
dc.contributor.authorTewari, Kamal-
dc.contributor.authorYadav, Shweta-
dc.contributor.authorJoshi, Sumit-
dc.contributor.authorSingh, Brajesh-
dc.contributor.authorMukherjee, Falguni-
dc.date.accessioned2012-03-16T12:06:24Z-
dc.date.available2012-03-16T12:06:24Z-
dc.date.issued2012-03-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/13739-
dc.description239-242en_US
dc.description.abstractSafety and immunogenicity of Brucella abortus RB51 vaccine has been evaluated in an organised dairy farm in India. All the cattle (n=29) vaccinated with strain RB51 ‘responded’ to the vaccine as demonstrated by iELISA using acetone killed strain RB51 antigen. The percentage responders at day 35, 60 and 90 post vaccination were 100%, 95% and 20%, respectively. Strain RB51 was able to elicit a good IFN- response from vaccinated animals. The post-vaccination time point analysis indicated that the cumulative IFN- response of whole blood from vaccinates stimulated with heat killed RB51 antigen was elicited in 80% of calves at 60 days post vaccination. Absence of strain RB51 in the secretions and excretion and lack of local or systemic reaction indicated the safety of the vaccine.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.50(03) [March 2012]en_US
dc.subjectBrucellosisen_US
dc.subjectCattleen_US
dc.subjectRB51en_US
dc.subjectVaccineen_US
dc.titleSafety and immunogenicity of Brucella abortus strain RB51 vaccine in cross bred cattle calves in Indiaen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.50(03) [March 2012]

Files in This Item:
File Description SizeFormat 
IJEB 50(3) 239-242.pdf59.4 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.